Ellagic acid increases implantation rates with its antifibrotic effect in the rat model of intrauterine adhesion
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Gulistan Sanem Saribas und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences, Gulhane Faculty of Medicine, Department of Histology and Embryology, Ankara, Turkey; Kirsehir Ahi Evran University, Fa…. Hauptthemen laut MEDLINE: Ellagic Acid, Uterine Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Intrauterine adhesions (IUA) are defined as the adhesion of opposing endometrial tissue with dense fibrous adhesive bands within the uterine cavity. With the increase in cesarean sections and endometrial surgical procedures, intrauterine adhesions have become a problem with increasing incidence and decreasing implantation. The purpose of the study was to investigate the effect of ellagic acid (EA), a phenolic compound, on fibrosis in IUA model rats. Another goal of the study was to increase endometrial receptivity with EA. The groups in the study were planned as control, DMSO, EA, IUA, IUA+DMSO, and IUA+EA, with 8 Sprague Dawley rats in each group. EA was administered at a dose of 100 mg/kg/day for 35 days. At the end of the experiment, the uterine tissues of the rats were removed. Histochemical staining was used to validate the IUA model and determine the degree of fibrosis. The levels of some fibrosis-related genes and proteins in the obtained uterine tissues were evaluated. In addition, implantation rates were determined. In our findings, it was observed that the fibrotic structure was decreased in the treated IUA+EA group compared to the IUA group, while fibrotic improvement was supported by down-regulation of TGFβ1 activity and up-regulation of BMP7 activity. The increase in the expression of the endometrial marker LIF with EA treatment was consistent with the increase in implantation rates with treatment. As a result of the study, it can be said that EA applied as a treatment against IUA causes healing in uterine tissue by reducing fibrosis and increases implantation rates by increasing endometrial receptivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Health Sciences, Gulhane Faculty of Medicine, Department of Histology and Embryology, Ankara, Turkey; Kirsehir Ahi Evran University, Faculty of Medicine, Department of Histology and Embryology, Kirsehir, T…
- Izmir Bakircay University, Faculty of Medicine, Department of Histology and Embryology, Izmir, Turkey.
- University of Kyrenia, Faculty of Medicine, Department of Histology and Embryology, Kyrenia, Northern Cyprus, Turkey.
- Kirsehir Ahi Evran University, Faculty of Medicine, Department of Medical Biology, Kirsehir, Turkey.
- Near East University, Faculty of Medicine, Department of Medical Biology, Nicosia, Northern cyprus, Turkey.
Zitieren
APA
Saribas, G. S., Akarca Dizakar, O., Ozogul, C., Celik, E., & Ergoren, M. C. (2023). Ellagic acid increases implantation rates with its antifibrotic effect in the rat model of intrauterine adhesion. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154499
Vancouver
Saribas GS, Akarca Dizakar O, Ozogul C, Celik E, Ergoren MC. Ellagic acid increases implantation rates with its antifibrotic effect in the rat model of intrauterine adhesion. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154499
BibTeX
@article{Saribas2023,
author = {Saribas, Gulistan Sanem and Akarca Dizakar, Ozen and Ozogul, Candan and Celik, Ekin and Ergoren, Mahmut Cerkez},
title = {Ellagic acid increases implantation rates with its antifibrotic effect in the rat model of intrauterine adhesion},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154499}
}
EUVIMED